Brief: Austar Lifesciences Sees Net Loss Of RMB22 Mln For Five Months Ended 31 May 2023
30/06/2023 09:59
June 30 (Reuters) - Austar Lifesciences Ltd 6118.HK :
* NET LOSS OF APPROXIMATELY RMB22 MILLION FOR FIVE MONTHS
ENDED 31
MAY 2023
* A LOSS ATTRIBUTABLE FOR SIX MONTHS ENDING 30 JUNE 2023
* EXPECTED LOSS DUE TO DECREASE IN REVENUE MAINLY FROM
BUSINESS
SEGMENTS OF LIQUID AND BIOPROCESS SYSTEM, AMONG OTHERS
Further company coverage: 6118.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Austar Lifesciences
See all newsAustar Lifesciences H1 profit drops on higher R&D spending
Brief: Austar Lifesciences Expects HY Profit Attributable Of RMB8 Million-RMB10 Million
Brief: Austar Lifesciences Posts FY Revenue RMB 1,530.7 Million
Brief: Austar Lifesciences Expects Profit Attributable Of Not Less Than RMB30 Million For FY
Brief: Austar Lifesciences Says Chen Yuewu Resigned As Executive Director